Benjamin Davies

Benjamin Davies is an experienced professional with a strong background in biomedical engineering, entrepreneurship, and corporate strategy. Currently serving as the Director of Algorithm Partnerships at Tempus Labs, Inc., Benjamin focuses on licensing diagnostic tests and biomarker validation. Previous roles include Interim CEO and Co-Founder of Helios Bio, where Benjamin co-invented a drug delivery platform and led its development into a commercial product, and Co-Founder of Vacuum Therapeutics, focusing on corporate strategy and fundraising in the biotechnology sector. Benjamin also held positions at Bridgewater Associates as an Investment Associate and conducted postdoctoral research at Harvard University, leading a team in microbiome research. Education includes a PhD in Biomedical/Medical Engineering and a Bachelor's degree in Biomedical Engineering and Commerce from the University of Sydney, along with postdoctoral research training at Harvard University.